PLoS ONE · 2014 · 32 citations · 18 references
MedicineNeurologyNeuroscienceAgingDementiaNeurodegenerationDementia PrognosisMultiple System AtrophyNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseTelomere DysfunctionCognitive PerformanceCognitive Performance ImpairmentCognitive Performance TestingDementia OnsetDementia With ParkinsonismOxidative Stress InjuryTelomere Length AnalysisTelomere Length Measurement
Telomere length (TL) is regarded as a marker of cellular aging due to the gradual shortening by each cell division, but is influenced by a number of factors including oxidative stress and inflammation. Parkinson's disease and atypical forms of parkinsonism occur mainly in the elderly, with oxidative stress and inflammation in afflicted cells. In this study the relationship between blood TL and prognosis of 168 patients with idiopathic parkinsonism (136 Parkinson's disease [PD], 17 Progressive Supranuclear Palsy [PSP], and 15 Multiple System Atrophy [MSA]) and 30 controls was investigated. TL and motor and cognitive performance were assessed at baseline (diagnosis) and repeatedly up to three to five years follow up. No difference in TL between controls and patients was shown at baseline, nor any significant difference in TL stability or attrition during follow up. Interestingly, a significant relationship between TL at diagnosis and cognitive phenotype at follow up in PD and PSP patients was found, with longer mean TL at diagnosis in patients that developed dementia within three years.
18
Telomere measurement by quantitative PCR
Richard Cawthon · Nucleic Acids Research · 2002 · 3.5K citations · Full text
Christopher G. Goetz, Werner Poewe, Olivier Rascol et al. · Movement Disorders · 2004 · 2.3K citations
Medicine, Neurology, Neuroscience +17
Consensus statement on the diagnosis of multiple system atrophy
Niall Quinn, Alberto Albanese, Yoav Ben‐Shlomo et al. · Journal of the Neurological Sciences · 1999 · 918 citations